Hybrid approach for management of end-stage heart failure in complex congenital heart disease

Abstract

Management of end-stage heart failure (ESHF) in children with congenital heart disease is challenging. We report a step-by-step hybrid procedure (transcatheter pulmonary valve and left mechanical assist device implantations) in a child with ESHF after repair of tetralogy of Fallot, as an effective bridge to transplant strategy.

Keywords

Congenital-heart-disease left-ventricular assist device transcatheter pulmonary valve

Get full access to this article

View all access options for this article.

References

Cedars

VanderPluym

Koehl

, et al. An Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of hospitalization, functional status, and mortality after mechanical circulatory support in adults with congenital heart disease. J Heart Lung Transplant 2018; 37(5): 619–630.

Morales

DLS

Rossano

VanderPluym

, et al. Third Annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) report: preimplant characteristics and outcomes. Ann Thorac Surg 2019; 107(4): 993–1004.

Griselli

Sinha

Jang

, et al. Mechanical circulatory support for single ventricle failure. Front Cardiovasc Med 2018; 5: 115.

Patel

Madanieh

Kosmas

, et al. Complications of continuous-flow mechanical circulatory support devices. Clin Med Insights Cardiol 2015; 9(Suppl. 2): 15–21.

Bernhardt

De By

TMMH

Reichenspurner

, et al. Isolated permanent right ventricular assist device implantation with the HeartWare continuous-flow ventricular assist device: first results from the European Registry for Patients with Mechanical Circulatory Support. Eur J Cardiothorac Surg 2015; 48(1): 158–162.

Wells

Villa

Simón Morales

DL.

The 50/50 cc total artificial heart trial: extending the benefits of the total artificial heart to underserved populations. Sem Thorac Cardiovasc Surg Pediatr Card Surg Annu 2017; 20: 16–19.

Alkashkari

Alsubei

Hijazi

ZM.

Transcatheter pulmonary valve replacement: current state of art. Curr Cardiol Rep 2018; 20(4): 27.

Cheatham

Hellenbrand

Zahn

, et al. Clinical and hemodynamic outcomes up to 7 years after transcatheter pulmonary valve replacement in the US melody valve investigational device exemption trial. Circulation 2015; 131(22): 1960–1970.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB